SCHEMBL13617044

SCHEMBL13617044

CC(C)(C)OCCCONC(=O)c1ccccc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 9/20 0.45
HDAC4 P56524 9/20 0.45
HDAC1 Q13547 9/20 0.45
HDAC7 Q8WUI4 9/20 0.45
HDAC2 Q92769 9/20 0.45
HDAC10 Q969S8 9/20 0.45
HDAC11 Q96DB2 9/20 0.45
HDAC8 Q9BY41 9/20 0.45
HDAC6 Q9UBN7 9/20 0.45
HDAC9 Q9UKV0 9/20 0.45
HDAC5 Q9UQL6 9/20 0.45
GRM4 Q14833 3/20 0.36
NAMPT P43490 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3584492 0.79 HDAC3 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12673343 0.79 HDAC3 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13499177 0.76 KCNA5 (0.43) ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL12337628 0.76 SMN1; SMN2 (0.47) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL6328702 0.70 CTSD (0.50) ALDH1A1HPGDSMN1; SMN2MAPTHTT
SCHEMBL27484400 0.70 TRIM24 (0.38) ALDH1A1HPGDSMN1; SMN2CYP1A2MAPT
SCHEMBL13985020 0.70 MAPT (0.50) ALDH1A1SMN1; SMN2MAPTCYP2C9HTT
SCHEMBL11892791 0.70 KMT2A (0.41) HDAC8ALDH1A1HPGDSMN1; SMN2CYP1A2
SCHEMBL11821772 0.70 TRIM24 (0.44) ALDH1A1HPGDSMN1; SMN2CYP1A2MAPT
SCHEMBL13985162 0.68 NPSR1 (0.56) NAMPTALDH1A1HPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2113500-A1 MAPK/ERK kinase inhibitors Takeda Pharmaceutical Company Limited (JP) 2009-11-04 EP disclosed